Private Ocean, LLC Omeros Corp Transaction History

Private Ocean, LLC

$1.08 Billion
Q2 2024

A detailed history of Private Ocean, LLC transactions in Omeros Corp stock. As of the latest transaction made, Private Ocean, LLC holds 1,250 shares of OMER stock, worth $8,687. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,250

Holding current value

$8,687

% of portfolio

0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$3.04 - $4.23 $3,800 - $5,287	1,250 New	1,250 $5,000
Q4 2023 Jan 22, 2024	BUY	$1.08 - $3.63 $1,350 - $4,537	1,250 New	1,250 $4,000
Q3 2022 Oct 21, 2022	BUY	$3.09 - $7.46 $3,862 - $9,325	1,250 New	1,250 $3,000
Q2 2022 Jul 25, 2022	SELL	$1.92 - $6.28 $2,400 - $7,850	-1,250 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$13.4 - $16.3 $16,750 - $20,375	1,250 New	1,250 $17,000
Q2 2021 Aug 02, 2021	SELL	$14.81 - $19.13 $18,512 - $23,912	-1,250 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$9.03 - $19.72 $11,287 - $24,650	1,250 New	1,250 $16,000
Q4 2019 Feb 05, 2020	SELL	$13.01 - $17.15 $16,262 - $21,437	-1,250 Closed	0 $0
Q3 2019 Nov 04, 2019	BUY	$14.55 - $20.56 $18,187 - $25,700	1,250 New	1,250 $21,000
Q2 2018 Aug 09, 2018	SELL	$10.79 - $24.44 $11,005 - $24,928	-1,020 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$9.0 - $20.16 $9,180 - $20,563	1,020 New	1,020 $11,000

Others Institutions Holding OMER

# of Institutions

120

Shares Held

25.6M

Call Options Held

228K

Put Options Held

630K

Ingalls & Snyder LLC New York, NY

4.54M
Shares

$31.5 Million
0.7% of portfolio
Black Rock Inc. New York, NY

4.1M
Shares

$28.5 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.26M
Shares

$22.7 Million
0.0% of portfolio
Stifel Financial Corp St. Louis, MO

1.9M
Shares

$13.2 Million
0.01% of portfolio
D. E. Shaw & Co., Inc. New York, NY

1.61M
Shares

$11.2 Million
0.01% of portfolio

View Full List

About OMEROS CORP

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $436M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

More about OMER

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Ocean, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Ocean, LLC with notifications on news.

Account